Updated

OpenEvidence, an ad-powered AI medical information startup now valued at 15 billion dollars, is booming in popularity among doctors despite lingering questions about the accuracy of its information, Ars Technica reported. The platform's rapid growth highlights how AI tools are increasingly embedded in clinical decision-making.